GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » DexCom Inc (WBO:DXCM) » Definitions » Sale Of Investment

DexCom (WBO:DXCM) Sale Of Investment : €3,114 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is DexCom Sale Of Investment?

DexCom's sale of investment for the three months ended in Mar. 2024 was €1,032 Mil. It means DexCom gained €1,032 Mil from selling investments. DexCom's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was €3,114 Mil.

Compared with last quarter (€659 Mil in Dec. 2023 ), DexCom gained more money from selling investments in Mar. 2024 (€1,032 Mil).


DexCom Sale Of Investment Historical Data

The historical data trend for DexCom's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DexCom Sale Of Investment Chart

DexCom Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,076.76 1,849.91 2,359.68 2,008.64 2,702.77

DexCom Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 651.56 793.23 629.10 659.32 1,032.06

DexCom Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €3,114 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DexCom Sale Of Investment Related Terms

Thank you for viewing the detailed overview of DexCom's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


DexCom (WBO:DXCM) Business Description

Traded in Other Exchanges
Address
6340 Sequence Drive, San Diego, CA, USA, 92121
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

DexCom (WBO:DXCM) Headlines

From GuruFocus

Q3 2023 Dexcom Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2023 Dexcom Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Dexcom Inc at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-22-2024

Dexcom Inc Investor Day Transcript

By GuruFocus Research 01-22-2024

Q4 2021 Dexcom Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2022 Dexcom Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Dexcom Inc at Wells Fargo Healthcare Conference Transcript

By GuruFocus Research 01-22-2024